• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Yi-Bin A. Chen, MD


  • Brunner AM, Campigotto F, Sadrzadeh H, Drapkin BJ, Chen YB, Neuberg DS, Fathi AT.Trends in all-cause mortality among patients with chronic myeloid leukemia: A Surveillance, Epidemiology, and End Results database analysis.Cancer. 2013 Apr 26.
  • Brunner AM, Sadrzadeh H, Feng Y, Drapkin BJ, Ballen KK, Attar EC, Amrein PC, McAfee SL, Chen YB, Scd DS, Fathi AT.Association between baseline body mass index (BMI) and overall survival among patients over age 60 with acute myeloid leukemia (AML).Am J Hematol. 2013 Apr 26.
  • Chen YB, Coughlin E, Kennedy KF, Alyea EP, Armand P, Attar EC, Ballen KK, Cutler C, Dey BR, Koreth J, McAfee SL, Spitzer TR, Antin JH, Soiffer RJ, Ho VT.Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia.Biol Blood Marrow Transplant. 2013 Apr 2.
  • Armand P, Welch S, Kim HT, LaCasce AS, Jacobsen ED, Davids MS, Jacobson C, Fisher DC, Brown JR, Coughlin E, Freedman AS, Chen YB.Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era.British Journal of Haematology. 2013 Mar;160(5):608-17.
  • Sadrzadeh H, Huck AE, Chen YB, Hasserjian RP, Fathi AT.Philadelphia chromosome positive B-cell lymphoblastic lymphoma isolated to bone.Leuk Lymphoma. 2013 Jan 30.
  • Fathi AT, Sadrzadeh H, Borger DR, Ballen KK, Amrein PC, Attar EC, Foster J, Burke M, Lopez HU, Matulis CR, Edmonds KM, Iafrate AJ, Straley KS, Yen KE, Agresta S, Schenkein DP, Hill C, Emadi A, Neuberg DS, Stone RM, Chen YB.Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response.Blood. 2012 Oct 16.
  • Fathi AT, Preffer FI, Sadrzadeh H, Ballen KK, Amrein PC, Attar EC, McAfee SL, Dillon L, Chen YB, Hasserjian RP.CD30 expression in acute myeloid leukemia is associated with FLT3-internal tandem duplication mutation and leukocytosis.Leuk Lymphoma. 2012 Sep 28.
  • Spitzer TR, Dey BR, Chen YB, Attar E, Ballen KK.The expanding frontier of hematopoietic cell transplantation.Cytometry. Part B, Clinical Cytometry. 2012 Sep;82(5):271-9.
  • Fathi AT, Chen YB, Carter BW, Ryan RJ.Case records of the Massachusetts General Hospital. Case 24-2012. A 38-year-old man with abdominal pain and altered mental status.N Engl J Med. 2012 Aug 9;367(6):552-63.
  • Chen YB, McDonough S, Hasserjian R, Chen H, Coughlin E, Illiano C, Park IS, Jagasia M, Spitzer TR, Cutler CS, Soiffer RJ, Ritz J.Expression of CD30 in patients with acute graft-versus-host disease.Blood. 2012 Jul 19;120(3):691-6.
  • Ballen KK, Cutler C, Yeap BY, McAfee SL, Dey BR, Attar EC, Chen YB, Haspel RL, Liney D, Koreth J, Ho V, Alyea EP, Soiffer RJ, Spitzer TR, Antin JH.Donor Derived Second Hematologic Malignancies after Cord Blood Transplantation.Biol Blood Marrow Transplant. 2010 Jul;16(7):1025-31.
  • Chen YB, Hochberg EP, Feng Y, Neuberg D, Rawal B, Motyckova G, Fisher DC, McAfee SL, Spitzer TR, Lacasce AS.Characteristics and outcomes after autologous stem cell transplant for patients with relapsed or refractory diffuse large B-cell lymphoma who failed initial rituximab, cyclophosphamide, adriamycin, vincristine, and prednisone therapy compared to patients who failed cyclophosphamide, adriamycin, vincristine, and prednisone.Leuk Lymphoma. 2010 May;51(5):789-96.
  • Pless ML, Chen YB, Copen WA, Frosch MP.Case records of the Massachusetts General Hospital. Case 9-2010. A 37-year-old woman with paresthesias and ataxia.N Engl J Med. 2010 Mar 25;362(12):1129-38.
  • Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Cin PD, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR.B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.Am J Surg Pathol. 2010 Mar;34(3):327-40.
  • Fenske TS, Hari PN, Carreras J, Zhang MJ, Kamble RT, Bolwell BJ, Cairo MS, Champlin RE, Chen YB, Freytes CO, Gale RP, Hale GA, Ilhan O, Khoury HJ, Lister J, Maharaj D, Marks DI, Munker R, Pecora AL, Rowlings PA, Shea TC, Stiff P, Wiernik PH, Winter JN, Rizzo JD, van Besien K, Lazarus HM, Vose JM.Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.Biol Blood Marrow Transplant. 2009 Nov;15(11):1455-64.
  • Ulrickson M, Aldridge J, Kim HT, Hochberg EP, Hammerman P, Dube C, Attar E, Ballen KK, Dey BR, McAfee SL, Spitzer TR, Chen YB.Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.Biol Blood Marrow Transplant. 2009 Nov;15(11):1447-54.
  • Chen YB, Kim HT, McDonough S, Odze RD, Yao X, Lazo-Kallanian S, Spitzer TR, Soiffer R, Antin JH, Ritz J.Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.Biol Blood Marrow Transplant. 2009 Sep;15(9):1066-76.
  • Chen YB,LaCasce AS.Enzastaurin.Expert Opin Investig Drugs. 2008 Jun;17(6):939-44. Review.
  • Chen YB, Spitzer TR.Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors.Leukemia. 2008 Jan;22(1):31-41. Review.
  • Chen YB, Rahemtullah A, Hochberg E.Primary effusion lymphoma.Oncologist. 2007 May;12(5):569-76. Review.